CIK 0001770069 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | |
|---|---|
| Net income (USD) | -161.2 M |
| Diluted EPS (USD/shares) | -18.56 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-16 | 4 | 4 | 2026-10-15 |
| 2026-10-16 | 4 | 4 | 2026-10-15 |
| 2026-10-16 | 4 | 4 | 2026-10-15 |
| 2026-10-16 | 4 | 4 | 2026-10-15 |
| 2026-10-16 | 4 | 4 | 2026-10-15 |
| 2026-10-16 | 4 | 4 | 2026-10-15 |
| 2026-10-15 | 144 | 144 | |
| 2026-10-15 | 144 | 144 | |
| 2026-10-15 | 144 | 144 | |
| 2026-10-15 | 144 | 144 | |
| 2026-10-15 | 144 | 144 | |
| 2026-10-15 | 144 | 144 | |
| 2026-10-15 | 144 | 144 | |
| 2026-09-23 | EFFECT | EFFECT items ,, | |
| 2026-09-23 | 424B3 | 424B3 | |
| 2026-09-18 | S-1/A | S-1/A | |
| 2026-09-18 | 4 | 4 | 2026-09-16 |
| 2026-09-16 | 144 | 144 | |
| 2026-09-09 | S-1 | S-1 | |
| 2026-08-20 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-08-19 | 4 | 4 | 2026-08-17 |
| 2026-08-19 | 4 | 4 | 2026-08-17 |
| 2026-08-19 | 4 | 4 | 2026-08-17 |
| 2026-08-19 | 4 | 4 | 2026-08-17 |
| 2026-08-19 | 4 | 4 | 2026-08-17 |
Forms on file (last 1,000): 4 82, 144 45, 3 17, 8-K 11, D 6, 144/A 5, DRS/A 4, SCHEDULE 13G 3. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=MPLT (0.002 USD), /gw/filings/filings?ticker=MPLT&form=8-K, /gw/filings/facts?ticker=MPLT&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange